Filing Details
- Accession Number:
- 0001415889-21-006155
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-21 16:16:14
- Reporting Period:
- 2021-12-17
- Accepted Time:
- 2021-12-21 16:16:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 861838 | Idera Pharmaceuticals Inc. | IDRA | Biological Products, (No Disgnostic Substances) (2836) | 043072298 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1556327 | J. John Kirby | C/O Idera Pharmaceuticals, Inc. 505 Eagleview Boulevard, Suite 212 Exton PA 19341 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-12-17 | 10,000 | $0.62 | 37,632 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
